In this work, Yan et al, (2024), provide mechanistic and functional insights into how mutant FLT3 hijacks mitochondrial gene expression and biogenesis to promote AML growth and suggest therapeutic interventions (see Fig. 1). The gene discussed is FLT3; the disease is acute myeloid leukemia.